
- /
- Supported exchanges
- / US
- / BBLG.NASDAQ
Bone Biologics Corp (BBLG NASDAQ) stock market data APIs
Bone Biologics Corp Financial Data Overview
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Bone Biologics Corp data using free add-ons & libraries
Get Bone Biologics Corp Fundamental Data
Bone Biologics Corp Fundamental data includes:
- Net Revenue:
- EBITDA: -824 964
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bone Biologics Corp News

Bone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share
(RTTNews) - Bone Biologics Corporation (BBLG), a developer of orthobiologic products for spine fusion, has priced a public offering of 1,250,000 shares of common stock, Series D warrants, and Series E...


Bone Biologics prices $5M public offering with warrants; shares up 45%
* Bone Biologics (NASDAQ:BBLG [https://seekingalpha.com/symbol/BBLG]) priced a public offering of 1.25M shares (or equivalents) at $4/share. * The offering includes Series D and Series E warrants ...

Why Bone Biologics Is Rising In Pre-market?
(RTTNews) - Bone Biologics (BBLG) announced the filing of a patent application with the United States Patent and Trademark Office for its NELL-1 protein. The patent application is directed to composit...

Bone Biologics regains Nasdaq compliance with minimum bid price rule; shares down
* Bone Biologics (NASDAQ:BBLG [https://seekingalpha.com/symbol/BBLG]) announced it has regained compliance with Nasdaq concerning the $1 minimum bid price requirement. * BBLG met the requirement a...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.